
ASSESSING THE RISK OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS BY THE COMBINED PATTERN OF RETINOLBINDING PROTEIN-4, HIGH MOLECULAR WEIGHT ADIPONECTIN AND BODY MASS INDEX
Author(s) -
Л. А. Атраментова,
Н. А. Кравчун,
В. В. Полторак,
M. Y. Gorshunska,
E. Jаnsen,
Nataliya Krasova,
Zhanna Leshchenko,
A. I. Gladkih,
T. V. Tyzhnenko,
Olga Plohotnichenko,
Y. A. Opaleiko,
A. K. Pochernyaev,
I. P. Dunaeva
Publication year - 2021
Publication title -
problemi endokrinnoï patologìï
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.141
H-Index - 2
eISSN - 2518-1432
pISSN - 2227-4782
DOI - 10.21856/j-pep.2015.3.02
Subject(s) - adiponectin , body mass index , medicine , type 2 diabetes mellitus , fatty liver , endocrinology , nonalcoholic fatty liver disease , diabetes mellitus , obesity , disease , gastroenterology , insulin resistance
The diagnostic model to highlight the high-risk groups of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus by the level of retinol-binding protein-4, high molecular weight adiponectin and body mass index using discriminant analysis was developed.